Exosens (LON:0EXO)
London
· Delayed Price · Currency is GBP · Price in EUR | Market Cap | 1.83B |
| Revenue (ttm) | 325.89M |
| Net Income (ttm) | 21.11M |
| Shares Out | n/a |
| EPS (ttm) | 0.50 |
| PE Ratio | 86.83 |
| Forward PE | 26.19 |
| Dividend | 0.08 (0.20%) |
| Ex-Dividend Date | May 28, 2025 |
| Volume | 112,000 |
| Average Volume | 186,925 |
| Open | 42.60 |
| Previous Close | n/a |
| Day's Range | 42.60 - 42.60 |
| 52-Week Range | 17.16 - 44.80 |
| Beta | n/a |
| RSI | 73.13 |
| Earnings Date | Jul 30, 2025 |
About Exosens
Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultra violet, short and long wave infrared, visible - near infrared, and mid wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensifiers for... [Read more]
Financial Performance
In 2024, Exosens's revenue was 394.08 million, an increase of 35.04% compared to the previous year's 291.82 million. Earnings were 25.53 million, an increase of 247.12%.
Financial numbers in EUR Financial StatementsNews
Exosens reaffirms 2024 outlook as NATO demand lifts sales
Exosens reaffirms 2024 outlook as NATO demand lifts sales
Exosens: Spectral And Imaging Opportunity With Attractive End Markets
Exosens, a leader in defense and industrial markets, had 35% revenue growth in 2024. It has 22% stock upside and growth-driven potential. Click to read more on EXOSF.